The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits...
Date First Received: November 30, 2006
Last Updated: August 17, 2007
Verified by: Innovative Medical, August 2007
Clinical Trial Phase: Phase 4 | Start Date:
Overall Status: Completed
Brief Summary
Condition Keyword(s):
The purpose of this study is to compare patient outcomes in following cataract surgery in patients randomized to one of two surgical kits.
Study Type: Interventional
Study Design: Randomized, Double-Blind, Active Control, Parallel Assignment
Intervention(s) in this Clinical Trial
- Drug: Gatifloxacin
- Drug: Ketorolac LS
- Drug: Pred Forte
- Drug: Moxifloxacin
- Drug: Nepafenac
- Drug: EconoPred Plus
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Males or females scheduled to undergo cataract surgery
- Patients can be receiving monofocal IOLs only
- Likely to complete all study visits and able to provide informed consent
- Visual potential of 20/25 or better
Exclusion Criteria:
- Known contraindications to any study medication or ingredients
- Active ocular diseases or uncontrolled systemic disease
- Active ocular allergies
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: N/A
Clinical Trial Sponsor Information
Lead Sponsor: Innovative Medical
Overall Clinical Trial Officials and Contacts
William Trattler, MD Principal Investigator The Center For Excellence in Eye Care
Additional Information
Information obtained from ClinicalTrials.gov on September 04, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00407017
Study ID Number: 5264-T
ClinicalTrials.gov Identifier: NCT00407017
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
